Press Releases

RT Extends KeepZone’s Exclusive Appointment as Its Representative in Canada and Mexico Tel Aviv, Israel, July 20, 2026 (GLOBE NEWSWIRE) -- Nexera Technologies Ltd ("Nexera" or the "Company") (NASDAQ:NEXR, NEXRW)), a data-driven company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI") driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has facilitated the first purchase order under the representation agreement dated as of January 1, 2026 with RT LTA Systems Ltd. ("RT"), a global leader in the design, development and manufacturing of the SkyStar™ family of ae

Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts Includes headline Phase 1 monotherapy data for TLN-121 in relapsed or refractory lymphomas with overall response rate of 84%, complete response rate of 32% and no observed dose-limiting toxicities Sue Desmond-Hellmann, renowned industry veteran, joined Treeline’s Board of Directors BOSTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB) ("Standard BioTools") today announced the filing of a registration statement on Form S-4 with

Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - Seabridge Gold Inc. (TSX:SEA) (NYSE:SA) ("Seabridge" or the "Company") has executed an unsecured, short-term loan agreement (the "Loan") with a strategic investor for up to US$100 million.Seabridge Chair and CEO Rudi Fronk commented: "We are pleased to secure financing to support the significant investments we are making in our summer season work programs at our 100% owned KSM Project. Our 2026 work programs at KSM include building of roads to provide improved access to future infrastructure areas and the collection of geotechnical, metallurgical and environmental data from drilling, test pitting and sampling required to support KSM's feas

Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo®)Early clinical activity observed: Phase 1 dose-escalation data show early tumor reductions in patients with Fibroblast Growth Factor Receptor (FGFR)3-altered and wild-type overexpressing tumors. Signal activity including confirmed partial responses in heavily pretreated patients in multiple tumor types. Differentiated safety profile: No dose-limiting toxicities and no FGFR inhibitor-class toxicities observed, supporting a potentially broader therapeutic index than approved FGFR tyrosine kinase inhibitors (TKIs).Potential to expand the addressable FGFR3 population

NEW YORK, July 20, 2026 /PRNewswire/ -- Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND, ", Lindblad", , the ", Company", )), a global provider of expedition cruises and adventure travel experiences, will report 2026 second quarter financial results on Monday, August 3, 2026, before the market opens, and will host an audio conference webcast to discuss the results at 9:00 am Eastern Time. The webcast can be accessed on the Company's website at investors.expeditions.com, or at https://events.q4inc.com/attendee/736341126.To participate in the Q&A, use the analyst registration, https://events.q4inc.com/analyst/736341126?pwd=ezWQ4

BTQ and TIDAL PWR to develop a repeatable architecture for quantum-enabled data centers, trusted supply chains, procurement standards, and secure deployment models for large-scale AI and advanced computing infrastructureVANCOUVER, BC, July 20, 2026 /CNW/ -- BTQ Technologies Corp. ("BTQ" or the "Company") (NASDAQ:BTQ) (CBOE CA: BTQ), a global technology company building the trust infrastructure for the quantum era, is pleased to announce a strategic collaboration with TIDAL PWR, a Texas-based developer of power generation and data center infrastructure for AI and advanced computing. TIDAL PWR is focused on one of the most import

IM-3050 is a fibroblast activation protein (FAP)-targeted radioligand therapy designed to deliver radioactive lutetium-177 directly to FAP-expressing cells.The Phase 1 trial is designed to evaluate the safety, tolerability, dosimetry, pharmacokinetics, and preliminary anti-tumor activity of IM-3050 in participants with FAP-expressing advanced solid tumors.Immunome, Inc. (NASDAQ:IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the first patient has been dosed in the Phase 1, first-in-human trial of IM-3050, an investigational FAP-targeted radioligand therapy being evaluated in patients with FAP-expressing a

Anduril and Archer today unveiled a jointly-developed series hybrid-electric VTOL platform built to serve both defense and commercial applications. Anduril showcased the defense variant, Thunder, a Group 5 autonomous attack rotorcraft specifically designed to multiply the combat power of current and next-generation crewed attack and assault aircraft. The two companies have built what they believe to be a step change in vertical lift: a new class of autonomous aircraft with the speed, range, payload and operating cost that defense and commercial missions demand. Archer plans to announce the first commercial customers later this week. Anduril and Archer Aviation (NYSE:ACHR) today

BURLINGTON, Mass. and JERUSALEM, July 20, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced a $3 million minority equity investment in Radial Health, Inc. ("Radial"), a management services organization supporting a leading network of Brain Medicine clinics across the country. The investment was made as part of Radial's previously-announced Series A financing, and BrainsWay joins other leading investors in Radial, including General Catalyst, Floating Point Capital, Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and Diede van La

- Priority Review granted; PDUFA target action date set for January 21, 2027 - - Submission for Accelerated Approval based on dystrophin as a surrogate endpoint - - In the registrational expansion cohort of the DELIVER trial, treatment with z-rostudirsen once every 4 weeks resulted in a robust and statistically significant increase in dystrophin production with functional improvement observed across multiple clinical endpoints and a favorable safety profile1 - WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today

WINNIPEG, Manitoba, July 20, 2026 (GLOBE NEWSWIRE) -- Frontier Nuclear and Minerals Inc. (NASDAQ:FNUC) ("Frontier" or the "Company"), a nuclear fuel cycle company, today announced changes to its Board of Directors (the "Board") bringing fresh expertise and energy to Frontier’s leadership team as the Company pursues its nuclear fuel cycle strategy. The Board has appointed Joshua Girnun, a metals and mining investment expert, and Donal Carroll, a seasoned corporate finance leader, as new directors. The Company’s Nominating and Corporate Governance Committee has recommended all the current directors as nominees at the Company’s upcoming annual general meeting of shareholders to be held on Au

StandardAero, Inc. (NYSE:SARO) will report its second quarter 2026 earnings results after the market closes on Thursday, August 6, 2026. StandardAero will hold a conference call to discuss the results at 5:00 PM ET that day. A live webcast of the conference call will be made available on the Events section of StandardAero’s investor relations website at https://ir.standardaero.com/news-events/events. The earnings release and presentation will also be posted to the investor relations website prior to the conference call. The conference call may also be accessed by dialing (877) 407-9762 or (201) 689-8538 for telephone access to the live call. Please click here for international toll-free

Entering the High Efficiency Water Heating Market Zurn Elkay Water Solutions Corporation (NYSE:ZWS) today announced it has signed an agreement to acquire Intellihot, Inc., a privately-held leader in tankless water heater solutions serving the healthcare, education, hospitality and commercial end markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720021781/en/"We are excited about Intellihot, an earlier-stage technology disruptor in the tankless water heating market for commercial and institutional applications," said Todd A. Adams, Chairman and CEO of Zurn Elkay. "This transaction will be a strong initial step into an

Project to power the equivalent of approximately 400 homesThis news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated June 5, 2025 to its short form base shelf prospectus dated May 7, 2025TORONTO, July 20, 2026 /CNW/ -- PowerBank Corporation (NASDAQ:PBK) (Cboe CA: PBK) (FSE: 103) ("PowerBank" or the "Company"), a leader in independent energy development and asset ownership in North America, is pleased to announce it has executed a lease agreement on a 3.2 MW DC ground-mount solar project known as the Scofield project (the "Project"), in Broome County, New York. The Project is expected to be eligible for incentives under the New York

The renewed agreement extends USANA's role as the official nutrition partner of Nordiq Canada, supporting Canada's elite cross-country ski athletes through 2028 and beyondSALT LAKE CITY, July 20, 2026 /CNW/ -- USANA Health Sciences, Inc. (NYSE:USNA), a global leader in science-based nutrition, today announced a renewal of its official partnership with Nordiq Canada, the national governing body for cross-country skiing in Canada. Under the renewed agreement, USANA will continue supplying Nordiq Canada's elite athletes with premium, NSF Certified for Sport® nutritional products designed to support performance, normal muscle recovery after exercise, and long-term health—through the 2030 Olympic

Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will participate in a fireside chat at the "Health, Wellness & Longevity" Virtual Conference presented by Maxim Group LLC on Wednesday, July 22, 2026 at 2:00 p.m. ET (11:00 a.m. PT). The live webcast will be available at the following link: https://digital.maximgrp.com/events/health-wellness-longevity-07222026 A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event an

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced that it has raised its year-end AI Cloud annualized run-rate revenue ("ARR")1 target from $3.7bn to more than $4bn2, of which approximately 85% is now under contract following new multi-year cloud services contracts with leading AI developers representing $2.8bn in total contract value. IREN's customer base now includes Microsoft, NVIDIA, Perplexity, Figure AI, Together AI, Fluidstack, Fireworks AI, Fal AI, Hume AI, and a new leading AI developer, across both bare metal and managed cloud services. IREN remains selective in allocating capacity ahead of commissioning, prioritizing diversificatio

NORWALK, Conn., July 20, 2026 /PRNewswire/ -- Terex Corporation (NYSE:TEX) will host a conference call to review its second quarter 2026 financial results on Thursday, July 30, 2026 at 8:30 a.m. Eastern Time. Simon Meester, President and Chief Executive Officer, and Jennifer Kong-Picarello, Senior Vice President and Chief Financial Officer, will host the call. The Company's financial results will be issued and available at https://investors.terex.com prior to the call the morning of Thursday, July 30, 2026.Participants are encouraged to access the webcast 15 minutes prior to the starting time. The webcast will be available for

Conference Call Scheduled at 9am Eastern TimeAZOUR, Israel, July 20, 2026 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ:ITRN), announced that it will be releasing its second quarter 2026 results on Wednesday, August 12, 2026. The Company will be hosting a video conference call later that day via Zoom, starting at 9am Eastern Time, 6am Pacific Time and 4pm Israel time. On the call, management will review and present the results and will be available to answer investor questions.To participate in the Zoom call, please register at the following link:https://us06web.zoom.us/webinar/register/WN_mE4jXN-IS0ufW5K5ZyeaUg https://us06web.zoom.us/webinar/register/WN_FseStmWFR6SpOakhbm71owFol

HOUSTON, July 20, 2026 /PRNewswire/ -- Today Western Midstream Partners, LP (NYSE:WES) ("WES" or the "Partnership") announced that the board of directors of its general partner declared a quarterly cash distribution of $0.93 per unit for the second quarter of 2026, or $3.72 per unit on an annualized basis, which is in-line with the prior quarter's distribution. WES's second-quarter 2026 distribution is payable on August 14, 2026, to unitholders of record at the close of business on July 31, 2026.The Partnership plans to report its second-quarter 2026 results after market close on Wednesday, August 5, 2026. Management will host a conference call on Thursday, August 6, 2026, at 9:00 a.m. Centr